US EditionBioStem Technologies Announces Extension to File 2024 Annual Report with OTC - BioStem Technologies (OTC:BSEM)
Summary by Benzinga
1 Articles
1 Articles
All
Left
Center
1
Right
BioStem Technologies Announces Extension to File 2024 Annual Report with OTC - BioStem Technologies (OTC:BSEM)
POMPANO BEACH, Fla., April 01, 2025 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC:BSEM), a leading MedTech company specializing in the development, manufacturing, and commercialization of placental-derived products for advanced wound care, announces it has filed for an extension to submit its annual report for the year ended December 31, 2024 to the OTC The company is currently undergoing a mandatory Securities Exchange Commission (SEC) re…
·New York, United States
Read Full ArticleCoverage Details
Total News Sources1
Leaning Left0Leaning Right0Center1Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
